These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10674019)

  • 1. Vitamin D analogues suppress IGF-I signalling and promote apoptosis in breast cancer cells.
    Xie SP; Pirianov G; Colston KW
    Eur J Cancer; 1999 Nov; 35(12):1717-23. PubMed ID: 10674019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of vitamin D analogs with signaling pathways leading to active cell death in breast cancer cells.
    Pirianov G; Colston KW
    Steroids; 2001; 66(3-5):309-18. PubMed ID: 11179739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of insulin- and insulin-like growth factor-I-stimulated growth of human breast cancer cells by 1,25-dihydroxyvitamin D3 and the vitamin D3 analogue EB1089.
    Vink-van Wijngaarden T; Pols HA; Buurman CJ; Birkenhäger JC; van Leeuwen JP
    Eur J Cancer; 1996 May; 32A(5):842-8. PubMed ID: 9081364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D derivatives inhibit the mitogenic effects of IGF-I on MCF-7 human breast cancer cells.
    Xie SP; James SY; Colston KW
    J Endocrinol; 1997 Sep; 154(3):495-504. PubMed ID: 9379127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of vitamin D analogue CB1093, TNFalpha and ceramide on breast cancer cell apoptosis.
    Pirianov G; Colston KW
    Mol Cell Endocrinol; 2001 Feb; 172(1-2):69-78. PubMed ID: 11165041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of insulin-like growth factor I receptor signaling by the vitamin D analogue EB1089 in MCF-7 breast cancer cells: A role for insulin-like growth factor binding proteins.
    Rozen F; Pollak M
    Int J Oncol; 1999 Sep; 15(3):589-94. PubMed ID: 10427145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth inhibition of both MCF-7 and Hs578T human breast cancer cell lines by vitamin D analogues is associated with increased expression of insulin-like growth factor binding protein-3.
    Colston KW; Perks CM; Xie SP; Holly JM
    J Mol Endocrinol; 1998 Feb; 20(1):157-62. PubMed ID: 9513092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitive induction of apoptosis in breast cancer cells by a novel 1,25-dihydroxyvitamin D3 analogue shows relation to promoter selectivity.
    Danielsson C; Mathiasen IS; James SY; Nayeri S; Bretting C; Hansen CM; Colston KW; Carlberg C
    J Cell Biochem; 1997 Sep; 66(4):552-62. PubMed ID: 9282333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic low-calcaemic vitamin D(3) analogues inhibit secretion of insulin-like growth factor II and stimulate production of insulin-like growth factor-binding protein-6 in conjunction with growth suppression of HT-29 colon cancer cells.
    Oh YS; Kim EJ; Schaffer BS; Kang YH; Binderup L; MacDonald RG; Park JH
    Mol Cell Endocrinol; 2001 Oct; 183(1-2):141-9. PubMed ID: 11604234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 1,25 dihydroxyvitamin D3 and its analogues on induction of apoptosis in breast cancer cells.
    James SY; Mackay AG; Colston KW
    J Steroid Biochem Mol Biol; 1996 Jul; 58(4):395-401. PubMed ID: 8903423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D and systemic cancer: is this relevant to malignant melanoma?
    Osborne JE; Hutchinson PE
    Br J Dermatol; 2002 Aug; 147(2):197-213. PubMed ID: 12174089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiestrogen potentiation of antiproliferative effects of vitamin D3 analogues in breast cancer cells.
    Love-Schimenti CD; Gibson DF; Ratnam AV; Bikle DD
    Cancer Res; 1996 Jun; 56(12):2789-94. PubMed ID: 8665515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy.
    Díaz GD; Paraskeva C; Thomas MG; Binderup L; Hague A
    Cancer Res; 2000 Apr; 60(8):2304-12. PubMed ID: 10786699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiproliferative action of vitamin D-related compounds and insulin-like growth factor-binding protein 5 accumulation.
    Rozen F; Yang XF; Huynh H; Pollak M
    J Natl Cancer Inst; 1997 May; 89(9):652-6. PubMed ID: 9150190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of 1,25-dihydroxyvitamin D3 and tetradecanoylphorbol acetate on cell cycle and apoptosis of MCF-7 cells and a vitamin D3-resistant variant.
    Narvaez CJ; Welsh J
    Endocrinology; 1997 Nov; 138(11):4690-8. PubMed ID: 9348195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
    Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a vitamin D3-resistant MCF-7 cell line.
    Narvaez CJ; Vanweelden K; Byrne I; Welsh J
    Endocrinology; 1996 Feb; 137(2):400-9. PubMed ID: 8593782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of integrin and ceramide signalling pathways can inhibit the mitogenic effect of insulin-like growth factor I (IGF-I) in human breast cancer cell lines.
    Perks CM; Gill ZP; Newcomb PV; Holly JM
    Br J Cancer; 1999 Feb; 79(5-6):701-6. PubMed ID: 10070857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptotic regression of MCF-7 xenografts in nude mice treated with the vitamin D3 analog, EB1089.
    VanWeelden K; Flanagan L; Binderup L; Tenniswood M; Welsh J
    Endocrinology; 1998 Apr; 139(4):2102-10. PubMed ID: 9528999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of breast cancer cell growth by combined treatment with vitamin D3 analogues and tamoxifen.
    Vink-van Wijngaarden T; Pols HA; Buurman CJ; van den Bemd GJ; Dorssers LC; Birkenhäger JC; van Leeuwen JP
    Cancer Res; 1994 Nov; 54(21):5711-7. PubMed ID: 7923220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.